000 01185 a2200385 4500
005 20250513050200.0
264 0 _c19950330
008 199503s 0 0 eng d
022 _a0041-1337
040 _aNLM
_beng
_cNLM
100 1 _aLum, C T
245 0 0 _aClinical impact of replacing Minnesota antilymphocyte globulin with ATGAM.
_h[electronic resource]
260 _bTransplantation
_cFeb 1995
300 _a371-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAntilymphocyte Serum
_xadministration & dosage
650 0 4 _aDrug Administration Schedule
650 0 4 _aFollow-Up Studies
650 0 4 _aGraft Rejection
_xprevention & control
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aKidney Transplantation
650 0 4 _aRetrospective Studies
700 1 _aUmen, A J
700 1 _aKasiske, B
700 1 _aGoerdt, P
700 1 _aHeim-Duthoy, K L
700 1 _aAndersen, R C
700 1 _aOdland, M D
700 1 _aNey, A L
700 1 _aJacobs, D M
700 1 _aRao, K V
773 0 _tTransplantation
_gvol. 59
_gno. 3
_gp. 371-6
999 _c7870904
_d7870904